Business

Announcement on Voluntary Disclosure Regarding the Approval Notice for Drug Clinical Trials of the Investigational Anti-Tumor Drug JJH201601 Liposome for Injection

Announcement on Voluntary Disclosure Regarding the Approval Notice for Drug Clinical Trials of the Investigational Anti-Tumor Drug JJH201601 Liposome for Injection

articleJiangsu Jibeier Pharmaceutical Co. Ltd. Class AJuly 10, 20253/news/announcement-on-voluntary-disclosure-regarding-the-approval-notice-for-drug-clinical-trials-of-the-investigational-anti-tumor-drug-jjh201601-liposome-for-injection
Announcement on Voluntary Disclosure Regarding the Approval Notice for Drug Clinical Trials of the Investigational Anti-Tumor Drug JJH201601 Liposome for Injection

About this update from Jiangsu Jibeier Pharmaceutical Co. Ltd. Class A

Announcement on Voluntary Disclosure Regarding the Approval Notice for Drug Clinical Trials of the Investigational Anti-Tumor Drug JJH201601 Liposome for InjectionThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Jiangsu Jibeier Pharmaceutical Co. Ltd. Class A